Bookeditors, Clifford A. Hudis, Tiffany A. Traina.
Contents:
Advances in the management of triple-negative breast cancer / Tiffany A. Traina & Clifford A. Hudis
Etiology and risk factors / Laura Fejerman & Elad Ziv
Diagnosis and pathology / Govardhanan Nagaiah & Jame Abraham
Molecular subtypes and emerging therapeutic opportunities / Anastasia Constantinidou, Robin L. Jones & Jorge S. Reis-Filho
Molecular profile of triple-negative breast cancer / Leonel F. Hernandez-Aya & Ana Maria Gonzalez-Angulo
Role of metabolic rehabilitation-based approach in TNBC : biguanide metformin and more / Lev M. Berstein, Garik A. Dashyan & Vladimir F. Semiglazov
Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer / Mark Robson
Targeted therapies: EGFR inhibitors / Farrah M. Datko & Maura N. Dickler
Targeted therapies : other agents in clinical trials / Brian R. Haney, Nathan M. Shumway & George E. Peoples
Combined therapies and future directions / Anastasia Pazaiti & Ian S. Fentiman.